Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' Dee Pharmaceuticals Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Dee Pharmaceuticals Ltd since January 2007.
– Provides intelligence on Dee Pharmaceuticals Ltd's M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Dee Pharmaceuticals Ltd and its subsidiaries since 2007. – Information about key financial and legal advisors for Dee Pharmaceuticals Ltd's financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes Dee Pharmaceuticals Ltd's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Dee Pharmaceuticals Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Dee Pharmaceuticals Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
101 pages •
By Euromonitor International
• Nov 2020
Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than...
The Global Bioinformatics Partnering Terms and Agreements 2014 to 2020 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis Partnering...
The Global Gene Therapy Partnering Agreements 2010-2020 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...
The global pyrogen testing market size is projected to reach USD 1,689 million by 2025 from USD 927 million in 2020, at a CAGR of 12.7% during the forecast period. Market growth is driven by factors such as the rising incidence of infectious diseases and increasing pandemics frequency, increasing R & D in the pharmaceutical and biotechnology...
286 pages •
By The Business Research Company
• Nov 2020
CRISPR Technology Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global CRISPR technology market. Description: Where is the largest and fastest growing market for the CRISPR...
The Asia-Pacific PET packaging market in the pharmaceutical sector (henceforth, referred to as the market studied) was valued at USD 2652 million in 2019, and it is projected to reach USD 3540 million by 2025, registering a CAGR of 5.1% during the period of 2020-2025. Plastic packaging is becoming more popular than other products, as a plastic...
Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Injectable Drug Delivery Devicess pipeline products with...
Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Transmucosal Drug Delivery Devicess pipeline products...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.